CDKN2A and cancer: In a different study, transfection with pcDNA3.1-p16/pcDNA3.1-vi5-hisA-eEF1A2 plasmids led to eEF1A2 down-regulation through the increase in tumour-suppressor p16 and in turn inhibited cancer cell growth [61].